KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Cost of Revenue (2016 - 2025)

Astrana Health's Cost of Revenue history spans 16 years, with the latest figure at $858.9 million for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 111.95% year-over-year to $858.9 million; the TTM value through Sep 2025 reached $2.6 billion, up 77.75%, while the annual FY2024 figure was $1.8 billion, 50.48% up from the prior year.
  • Cost of Revenue for Q3 2025 was $858.9 million at Astrana Health, up from $576.8 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $858.9 million in Q3 2025 and bottomed at $136.2 million in Q2 2021.
  • The 5-year median for Cost of Revenue is $289.4 million (2023), against an average of $340.0 million.
  • The largest annual shift saw Cost of Revenue dropped 2.49% in 2021 before it surged 111.95% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $171.8 million in 2021, then soared by 47.3% to $253.1 million in 2022, then increased by 24.07% to $314.1 million in 2023, then soared by 95.74% to $614.7 million in 2024, then surged by 39.71% to $858.9 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Cost of Revenue are $858.9 million (Q3 2025), $576.8 million (Q2 2025), and $549.1 million (Q1 2025).